loadpatents
name:-0.025063991546631
name:-0.020891189575195
name:-0.00056791305541992
Yardley; John P. Patent Filings

Yardley; John P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yardley; John P..The latest application filed is for "enantiomers of o-desmethyl venlafaxine".

Company Profile
0.22.19
  • Yardley; John P. - King of Prussia PA
  • Yardley; John P. - Gulph Mills PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Enantiomers Of O-desmethyl Venlafaxine
App 20090326075 - Yardley; John P. ;   et al.
2009-12-31
Ethers of O-desmethyl venlafaxine
Grant 7,291,646 - Yardley , et al. November 6, 2
2007-11-06
Enantiomers of O-desmethyl venlafaxine
App 20070208084 - Yardley; John P. ;   et al.
2007-09-06
Enantiomers of N-Desmethyl venlafaxine
App 20070117870 - Yardley; John P. ;   et al.
2007-05-24
Enantiomers of N-desmethyl venlafaxine
App 20060205821 - Yardley; John P. ;   et al.
2006-09-14
Enantiomers of O-desmethyl venlafaxine
App 20060154992 - Yardley; John P. ;   et al.
2006-07-13
Enantiomers of N-desmethyl venlafaxine
App 20050267219 - Yardley, John P. ;   et al.
2005-12-01
Enantiomers of O-desmethyl venlafaxine
App 20050256206 - Yardley, John P. ;   et al.
2005-11-17
Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity
Grant 6,831,084 - Childers, Jr. , et al. December 14, 2
2004-12-14
Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
Grant 6,828,324 - Childers, Jr. , et al. December 7, 2
2004-12-07
Enantiomers of N-desmethyl venlafaxine
App 20040180966 - Yardley, John P. ;   et al.
2004-09-16
Enantiomers of O-desmethyl venlafaxine
App 20040176468 - Yardley, John P. ;   et al.
2004-09-09
Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity
App 20040162430 - Childers, Wayne E. JR. ;   et al.
2004-08-19
Ethers of o-desmethyl venlafaxine
App 20040147601 - Yardley, John P. ;   et al.
2004-07-29
Enantiomers of N-desmethyl venlafaxine
App 20030203972 - Yardley, John P. ;   et al.
2003-10-30
Ethers of O-Desmethyl venlafaxine
App 20030158253 - Yardley, John P. ;   et al.
2003-08-21
Enantiomers of O-desmethyl venlafaxine
App 20030149112 - Yardley, John P. ;   et al.
2003-08-07
Enantiomers of N-desmethyl venlafaxine
App 20020165284 - Yardley, John P. ;   et al.
2002-11-07
Enantiomers of O-desmethyl venlafaxine
App 20020161055 - Yardley, John P. ;   et al.
2002-10-31
Ethers of O-Desmethyl venlafaxine
App 20020037922 - Yardley, John P. ;   et al.
2002-03-28
Enantiomers of N-desmethyl venlafaxine
App 20020035158 - Yardley, John P. ;   et al.
2002-03-21
Enantiomers of O-desmethyl venlafaxine
App 20020022662 - Yardley, John P. ;   et al.
2002-02-21
Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
Grant 5,278,160 - Abou-Gharbia , et al. January 11, 1
1994-01-11
Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
Grant 5,254,552 - Abou-Gharbia , et al. October 19, 1
1993-10-19
Benzimidazole phosphono-amino acids
Grant 5,124,319 - Baudy , et al. June 23, 1
1992-06-23
Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity
Grant 5,010,078 - Abou-Gharbia , et al. April 23, 1
1991-04-23
Tertiary alkyl functionalized piperazine derivatives
Grant 4,988,814 - Abou-Gharbia , et al. January 29, 1
1991-01-29
Piperazinylalkylcarboxylic acid adamantylamides
Grant 4,921,958 - Abou-Gharbia , et al. May 1, 1
1990-05-01
Polycyclic-carbamic acid piperazinoalkyl esters and amides
Grant 4,882,432 - Abou-Gharbia , et al. November 21, 1
1989-11-21
Substituted phenylacetamides
Grant 4,761,501 - Husbands , et al. August 2, 1
1988-08-02
Oxazole and thiazole naphthalenes as antiallergic agents
Grant 4,754,043 - Kreft, III , et al. June 28, 1
1988-06-28
Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
Grant 4,661,596 - Kreft, III , et al. April 28, 1
1987-04-28
Substituted phenylacetonitriles
Grant 4,611,078 - Husbands , et al. September 9, 1
1986-09-09
2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
Grant 4,535,186 - Husbands , et al. August 13, 1
1985-08-13
Claudogenic-interceptive nonapeptide
Grant 4,272,432 - Yardley , et al. June 9, 1
1981-06-09
Cyclic undecapeptides related to somatostatin and intermediates therefor
Grant 4,133,805 - Yardley January 9, 1
1979-01-09
(N-Acetyl)-Pro-D-Phe-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt and intermediates
Grant 3,933,782 - Yardley January 20, 1
1976-01-20
P-Glu-D-p-F-Phe-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH.sub.2
Grant 3,928,308 - Yardley December 23, 1
1975-12-23
(N-propionyl) -gly-cys-lys-asn-phe-phe-trp-lys-thr-phe-thr-ser-cys-oh and intermediates
Grant 3,896,105 - Chai , et al. July 22, 1
1975-07-22
P-Glu-D-Phe-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-Gly-NH.sub.2 and intermediates
Grant 3,886,137 - Yardley May 27, 1
1975-05-27
P-glu-d-phe-t Rp-ser-tyr-d-ala-leu-arg-pro-gly-nh2-and Intermediates
Grant 3,855,199 - Foell , et al. December 17, 1
1974-12-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed